Clinical trial NCT02195739 - References

Smoking Cessation — Nicotine Replacement Therapy and Cardiovascular Disease

Citation(s)

•   British Medical Association and the Royal Pharmaceutical Society of Great Britain
  British National Formulary. Version 56. London; BNF Group; 2008.
•   Cahill K, Stead LF, Lancaster T
  Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD006103.
•   Fiore MC, Bailey WC, Cohen SJ, et al
  Treating tobacco use and dependence. Clinical practice guideline. Rockville (MD): US Department of Health and Human Services, Public Health Service, 2000
•   Le Foll B, George TP
  Treatment of tobacco dependence: integrating recent progress into practice. CMAJ. 2007 Nov 20;177(11):1373-80. Review. Erratum in: CMAJ. 2008 Mar 11;178(6):732.
•   Stead LF, Perera R, Bullen C, Mant D, Lancaster T
  Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000146. doi: 10.1002/14651858.CD000146.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD000146.
•   West R, McNeill A, Raw M
  Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax. 2000 Dec;55(12):987-99.

A Retrospective, Real-life Evaluation of the Cardiovascular Disease Risk Associated With Exposure to Pharmacological Smoking Cessation Interventions in a Representative UK Primary Care Patient Population.

Details for clinical trial NCT02195739